Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 701 - 750 out of 45,580

Document Document Title
WO/2013/170154A1
Isolated mutant Mycobacterium tuberculosis bacteria comprising a deletion in the ESAT-6 gene cluster region 3 (esx-3 region) are provided, as well as compositions comprising such, methods of production thereof and methods of use thereof.  
WO/2013/166863A1
Disclosed in the present invention are a preparation method of competent host cells and a method for rapidly and efficiently transferring an exogenous substance into the host cells, and uses thereof, wherein the core of the method lies i...  
WO/2013/168310A1
The present invention provides a method for producing an oxo fatty acid and a rare fatty acid, such as a conjugated fatty acid, a hydroxylated fatty acid, or a partially saturated fatty acid, using four types of enzymes (fatty acid hydra...  
WO/2013/170235A1
Embodiments provided herein generally relate to methods and materials for ultrasound-mediated introduction of exogenous substances into microorganisms. Some embodiments relate to methods of introducing an exogenous material into a microo...  
WO/2013/168680A1
This wastewater treatment system comprises: an anaerobic region to which wastewater that has not passed through a sedimentation tank, i.e., wastewater in which solids having a small size and a low specific gravity are contained as such w...  
WO/2013/166639A1
The invention relates to the field of microalgae culturing, in particular to a trap type carbon replenishing device for culturing microalgae of an opened pool and a carbon replenishing method thereof. The trap type carbon replenishing de...  
WO/2013/166703A1
A fungal strain XS3-3-2 CGMCC No.5776, preserved in China General Microbiological Culture Collection Center (CGMCC) with the preservation date on February 9, 2012 and the preservation number being CGMCC No.5776. The fugal strain XS3-3-2 ...  
WO/2013/168438A1
Provided is a novel protein having a lactase activity, which is stable at a pH value ranging from 1 to 2 and is highly active at a pH value ranging from 4 to 5. The present invention provides a protein having a lactase activity, which is...  
WO/2013/166460A1
Described are probes and methods for detecting antibiotic susceptibility of a specimen. The method comprises contacting the specimen with an oligonucleotide probe that specifically hybridizes with a target nucleic acid sequence region of...  
WO/2013/163893A1
Provided are a method for treating cancer or tumor by using modified bacteria as well as a therapeutic or prophylactic composition comprising the modified bacteria. The method may combine with other treatments such as chemotherapy, radia...  
WO/2013/164483A1
The present invention relates to truncated GIP analogues which comprise one or more substitutions as compared to wiid-type GIP and which may have the property of an altered, preferably increased GLP-1 activity, e.g. as assessed in in vit...  
WO/2013/165132A1
The present invention relates to the effect of providing JL-1 (KCTC 11782BP) microbial consortia having an increased number of Dehalococcoides sp. strains, and also relates to the effect of providing a microbial agent for biological puri...  
WO/2013/166374A3
The present invention relates to methods for producing a dried flavor, fragrance (e.g., odor), and/or color composition and products produced using the composition. The present invention also provides methods for producing a dried flavor...  
WO/2013/164479A3
A variant polypeptide having chymosin activity, wherein the variant has an amino acid sequence which, when aligned with the chymosin comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid re...  
WO/2013/165607A1
A novel Bacillus amylolilquefaciens strain BAC03, is isolated and characterized. This BAC03 strain provides protection against soil plant pathogen and enhances plant growth. Methods of using the strain are also provided.  
WO/2013/164479A2
A variant polypeptide having chymosin activity, wherein the variant has an amino acid sequence which, when aligned with the chymosin comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid re...  
WO/2013/162729A1
The introduction of tools to study, control or expand the inner-workings of algae has been slow to develop. Provided are embodiments of a molecular method based on guanidinium-rich molecular transporters (GR-MoTrs) for bringing molecular...  
WO/2013/159155A1
The present invention relates to a derivative bacterial strain of an avirulent, non-pathogenic Clostridium ghonii that is capable of arresting the growth of, regressing or destroying one or more solid tumours. The present invention furth...  
WO/2013/163613A3
Methods and materials useful for modulating the sensitivity of cells to an inhibitor of acetohydroxyacid synthase (AHAS) are disclosed. For example, nucleic acid molecules encoding AHAS large subunits are disclosed as well as methods for...  
WO/2013/159234A1
The present application relates to glycoengineered outer membrane vesicles obtained from recombinant, gram-negative bacteria comprising hetereologous DNA encoding an enzyme or enzymes that produce a heterologous glycan that replaces all ...  
WO/2013/163210A1
The invention provides, inter alia, systems, compositions, kits and methods for detecting an organism, such as a microbe, microorganism, pathogen, or organism associated with Hospital Associated Infections (HAIs). The systems, compositio...  
WO/2013/163590A3
The present invention relates to GH61 polypeptide variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of usin...  
WO/2013/162165A1
The present invention provides a method for producing large quantities of cellulase, comprising the steps of: (a) adding water to pulverized palm by-products, inoculating Aspergillus oryzae, which produces cellulase, and adding a nitroge...  
WO/2013/160270A1
The present invention relates to mutants of lactic acid bacteria which are resistant to the antibiotic ampicillin and which were found to give an increased texture when grown in milk while maintaining the other growth properties of the p...  
WO/2013/161814A1
The present invention provides an antibody which can bind to human CD69 specifically, has an activity of preventing allergic inflammations, and has a cross-reactivity with mouse CD69. The present invention also provides an antibody which...  
WO/2013/163654A3
A method for producing a secreted recombinant polypeptide sequence is provided. In some embodiments it comprises providing a recombinant microorganism comprising a recombinant nucleic acid comprising a first nucleic acid sequence encodin...  
WO/2013/162050A1
The purpose of the invention is to provide: a lactoferrin fusion protein that retains the bioactivity of natural lactoferrin, significantly prolongs the in vivo lifespan, and has better clinical utility than natural lactoferrin and recom...  
WO/2013/162330A1
The present invention relates to a method for preparing a chimeric mesenchymal stem cell population comprising a step of mixing and culturing tonsil tissue-derived mesenchymal stem cells obtained from different donors, and a chimeric mes...  
WO/2013/162707A1
According to an embodiment, a method of providing a biopolymer comprises: cryodesiccating a broth, wherein the broth comprises: (A) a biopolymer, wherein the biopolymer is an exopolysaccharide; and (B) a liquid growth medium. According t...  
WO/2013/159710A1
Provided is a method for improving the xylose consumption rate of Clostridium beijerinckii.By knocking out a transcription regulation factor xylR of Clostridium beijerinckii, knocking out araR of Clostridium beijerinckii and/or enhancing...  
WO/2013/162274A1
The present invention relates to a method for producing a mutated strain which produces D-lactic acid, to a mutated strain producing D-lactic acid which is produced by the method, and to a method for producing D-lactic acid comprising th...  
WO/2013/162035A1
Provided is an amadoriase which has high reactivity with an α-fructosyl hexapeptide (αF6P) originated from the β-chain amino terminal of glycated hemoglobin (HbA1c) and enables the satisfactory quantification of an αF6P that has been...  
WO/2013/161832A1
Provided is a method for culturing a microalga, which can reduce the cost for production of a microalga-originated biomass. Also provided are: a microalga which can form a biofilm on the surface of a liquid; a biofilm which is formed on ...  
WO/2013/161303A1
Provided are a bread yeast that functions to increase dough tensile strength, prevent molding, and realize a high sugar-fermenting force in high-sugar dough, as well as bread dough and bread that use the yeast. When this bread yeast is u...  
WO/2013/163292A3
A method of increasing the production a difunctional alkane in a microorganism that produces a difunctional alkane from alpha-keto acid by increasing the production of homocitrate in the cell relative to a wild-type or parent cell. The p...  
WO/2013/160413A1
The dairy industry today faces a problem of providing an alternative to adding sweeteners to fermented milk products in order to achieve the desired sweet taste without the added calories. Furthermore, it would be highly advantageous to ...  
WO/2013/163292A2
A method of increasing the production a difunctional alkane in a microorganism that produces a difunctional alkane from alpha-keto acid by increasing the production of homocitrate in the cell relative to a wild-type or parent cell. The p...  
WO/2013/161939A1
Provided is a method for culturing a fungus, which enables a mycelium of a basidiomycete to be grown into a fruiting body in a solid culture medium or a liquid culture medium and therefore can culture the basidiomycete with uniform quali...  
WO/2013/162478A1
There is provided a method of degrading a heterocyclic aldehyde compound comprising the step of treating the heterocyclic aldehyde compound with Enterobacter sp. microorganisms. There is also provided a method of degrading a carboxylic a...  
WO/2013/158913A1
The specification provides compositions and methods for treating cancer with non cancerous cell extracellular vesicles. Extracellular vesicles act as a surrogate microenvironment to reverse the drug-resistance or cancerous phenotype of c...  
WO/2013/157904A1
The present invention relates to a composition for promoting the growth of microalgae containing Exophiala oligosperma or a culture product thereof, a composition, which is added to a medium for culturing microalgae, containing the micro...  
WO/2013/156587A1
Disclosed herein are inventive stable homogenized biomass hetero-colloids, their production and uses. Such biomass hetero-colloids comprise biomass derived solid particle colloid matter and at least 15 % (w/w) biomass derived soluble col...  
WO/2013/157556A1
Provided is a decomposition accelerator used in purification (bioremediation) by microorganisms of soil contaminated by a volatile organic halogen compound, wherein said decomposition accelerator can quickly detoxify a volatile organic h...  
WO/2013/155864A8
Provided is a method for producing cordycepic acid by means of the liquid fermentation of Cordyceps militaris, comprising the steps of: (1) inoculating strains of Cordyceps militaris into the PD liquid fermentation medium, activating the...  
WO/2013/156635A1
The present invention relates to a microorganism belonging to the Tetraselmis suecica microalgae species with Spanish Algae Bank access number BEA D01_11. Furthermore, the present invention relates to the use of this strain for the produ...  
WO/2013/155864A1
Provided is a method for producing cordycepic acid by means of the liquid fermentation of Cordyceps militaris, comprising the steps of: (1) inoculating strains of Cordyceps militaris into the PD liquid fermentation medium, activating the...  
WO/2013/158900A1
A composition of matter comprising: a combination of a phytate and a plurality of microorganisms comprising a Trichoderma virens fungus, a Bacillus amyloliquefaciens bacterium, and one or a plurality of mycorrhizae fungi that is placed i...  
WO/2013/159055A1
The invention generally relates to the production of a fatty alcohol composition from recombinant microbial cells. The fatty alcohols are produced by expressing a gene encoding a heterologous fatty alcohol forming acyl-CoA reductase ("FA...  
WO/2013/159005A3
The present invention relates to modified filamentous fungal organisms having improved activity profiles with respect to the conversion of complex carbohydrates into simple sugars from cellulosic materials, including fungal organisms bel...  
WO/2013/158061A1
Recombinant Mycobacteria (rMyc) which contain sequences encoding a heparin- binding hemagglutinin (HBHA) fusion protein are provided, as are methods of making and using the rMyc and the fusion protein. The fusion protein includes an amin...  

Matches 701 - 750 out of 45,580